✦ LIBER ✦

Follow-up of cognitive functioning in patients with small cell lung cancer

✍ Scribed by Ansel G.M. van Oosterhout; Peter J. Boon; Peter J. Houx; Guul P.M. ten Velde; Albert Twijnstra

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 318 KB
Volume: 31
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)00579-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of cognitive function in pati

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation

✍ Ritsuko Komaki; Christina A. Meyers; Dong M. Shin; Adam S. Garden; Kevin Byrne; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Follow up neurological evaluation in pat

Follow up neurological evaluation in patients with small cell Lung Cancer (SCLC) treated with prophylactic cranial irradiation and chemotherapy

✍ R. Catane; I. Yaar; A. Lichter; H. Brereton; L. Brody; R. Dunnick; J. Schwade; E 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Neurologic disorders in patients with sm

Neurologic disorders in patients with small cell lung cancer

✍ Jean-Paul Sculier; Ronald Feld; William K. Evans; Gerrit Deboer; Frances A. Shep 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

Neurocognitive function in patients with

Neurocognitive function in patients with small cell lung cancer : Effect of prophylactic cranial irradiation

✍ David R. Grosshans; Christina A. Meyers; Pamela K. Allen; Samuel D. Davenport; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract ## BACKGROUND. The use of prophylactic cranial irradiation (PCI) in patients with small cell lung cancer (SCLC) has been tempered by fears of detrimental effects on cognitive function. Neuropsychologic testing was prospectively conducted before and after PCI to evaluate its effects on

Treatment of small-cell lung cancer in e

Treatment of small-cell lung cancer in elderly patients

✍ Athanasios G. Pallis; Frances A. Shepherd; Denis Lacombe; Cesare Gridelli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Neoadjuvant chemotherapy in marginally r

Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients

✍ Dr. Arthur Skarin; Maxine Jochelson; Thomas Sheldon; Arnold Malcolm; Peter Oliyn 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 822 KB

Forty-one patients with marginally resectable stage 111 Mo non-small cell lung cancer (NSCLC) were entered into a study evaluating neoadjuvant cyclophosphamide, adriamycin, and cisplatin chemotherapy (CAP) followed by radiotherapy and subsequent resection. Postoperative radiotherapy and additional C